Nørskov Anne Storgaard, Møller Amalie Lykkemark, Torp-Pedersen Christian, Domínguez Helena, Blomberg Stig Nikolaj, Christensen Helle Collatz, Kragholm Kristian, Prescott Eva, Lønborg Jacob, Halili Andrim, Folke Fredrik, Bang Casper Niels
Department of Cardiology, Copenhagen University Hospital - North Zealand, Hillerød, Denmark.
Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.
JACC Adv. 2024 Sep 19;3(10):101268. doi: 10.1016/j.jacadv.2024.101268. eCollection 2024 Oct.
Ongoing opioid treatment can potentially modify symptoms of myocardial infarction (MI) and cause a lack of recognition and treatment delay.
The purpose of this study was to examine MI symptoms and the time to hospitalization for patients in ongoing opioid treatment compared to patients without ongoing opioid treatment.
We evaluated calls to the Copenhagen Emergency Medical Services in Denmark from 2014 to 2018. Calls were included when followed by hospitalization and a diagnosis of MI. Symptoms of MI and the time from call to hospitalization in patients in ongoing opioid treatment initiated prior to the onset of MI were compared to a control group of MI patients without opioid treatment.
In total, 6,633 calls were included; 552 calls from patients in opioid treatment and 6,081 calls from controls. Patients in opioid treatment were older and had more comorbidities than controls. Chest pain was less prevalent in MI patients in opioid treatment compared to controls (adjOR: 0.70; 95% CI: 0.57-0.85). The median time from the call to hospitalization was longer in patients in opioid treatment than in controls (50 vs 47 minutes; = 0.006).
In calls to the Emergency Medical Services, opioid treatment initiated prior to the onset of MI was associated with less frequent chest pain in MI. Therefore, awareness of ongoing opioid treatment may improve telephone triage of patients with MI, as symptom presentation in opioid-treated patients may differ and potentially challenge and delay the emergency response.
正在进行的阿片类药物治疗可能会改变心肌梗死(MI)的症状,并导致识别不足和治疗延迟。
本研究的目的是比较正在接受阿片类药物治疗的患者与未接受阿片类药物治疗的患者的MI症状及住院时间。
我们评估了2014年至2018年丹麦哥本哈根紧急医疗服务中心接到的电话。若后续有住院治疗且诊断为MI,则纳入该电话记录。将MI发作前开始接受阿片类药物治疗的患者的MI症状及从电话接收到住院的时间与未接受阿片类药物治疗的MI患者对照组进行比较。
总共纳入6633个电话记录;其中552个来自接受阿片类药物治疗的患者,6081个来自对照组。接受阿片类药物治疗的患者比对照组年龄更大,合并症更多。与对照组相比,接受阿片类药物治疗的MI患者胸痛的发生率较低(调整后的比值比:0.70;95%置信区间:0.57-0.85)。接受阿片类药物治疗的患者从电话接收到住院的中位时间比对照组更长(50分钟对47分钟;P = 0.006)。
在紧急医疗服务中心接到的电话中,MI发作前开始的阿片类药物治疗与MI患者胸痛频率较低有关。因此,了解正在进行的阿片类药物治疗可能会改善MI患者的电话分诊,因为接受阿片类药物治疗的患者的症状表现可能不同,可能会对紧急反应构成挑战并导致延迟。